Steve McPhail joined Fluidigm (NASDAQ: FLDM) as General Manager of Applied Markets in May 2015. Prior to joining Fluidigm, Steve spent 12 years with EA, a genomic services company, beginning in February 2003 as its President and Chief Executive Officer. In 2012, Steve successfully sold EA to Quintiles Transnational Corporation, where he served as Global Head of Genomic Laboratory Operations until March 2015. Steve has spent his career serving companies in the diagnostic, biotechnology and medical device markets. He has extensive experience in building exceptional management teams, establishing global distribution networks, and developing and executing sales, marketing and operational plans. Steve earned his B.S. in Biology from San Diego State University. In addition to the serving on the Board of Directors of ImproveCareNow Inc., he serves on the Board of Visitors of the North Carolina Children’s Hospital and on the Board of Managers of Genome ID Group LLC.